[Progress in therapy for and diagnosis of diabetic neuropathies].
Baba
Masayuki
M
D000125:Achilles Tendon / Q000502:physiology; D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors; D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001284:Atrophy; D003929:Diabetic Neuropathies / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007866:Leg; D018482:Muscle, Skeletal / Q000473:pathology; D010147:Pain Measurement; D012018:Reflex / Q000502:physiology; D012236:Rhodanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D012867:Skin / Q000473:pathology; D053778:Thiazolidines / Q000627:therapeutic use; D014732:Vibration
D000929:Antidepressive Agents, Tricyclic; D004791:Enzyme Inhibitors; D007004:Hypoglycemic Agents; D053778:Thiazolidines; C038131:epalrestat; D012236:Rhodanine; D000449:Aldehyde Reductase